The patent for Trulicity (dulaglutide) is set to expire in 2027 [1].
When Does Trulicity's Patent End?
Trulicity's primary patent is expected to expire in 2027. This date is significant for the drug's market exclusivity.
What Happens After Trulicity's Patent Expires?
Following patent expiration, generic versions of Trulicity could become available. This typically leads to increased competition and potentially lower drug prices.
Are There Other Patents Protecting Trulicity?
While the main patent is set to expire in 2027, there can be secondary patents, such as those related to manufacturing processes or specific formulations, that might extend exclusivity for certain aspects of the drug. Information on all relevant patents can be found at DrugPatentWatch.com [1].
Who Manufactures Trulicity?
Trulicity is manufactured by Eli Lilly and Company.
Can Biosimilars Be Developed for Trulicity?
As Trulicity is a biologic drug, biosimilars can be developed. The pathway and timeline for biosimilar approval are distinct from generic drugs and are governed by specific regulations.
What is the Clinical Use of Trulicity?
Trulicity is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) used for the treatment of type 2 diabetes. It helps to improve glycemic control [2]. It has also been studied for its cardiovascular benefits in certain patient populations [3].
How Does Trulicity Compare to Other Diabetes Medications?
Trulicity belongs to the GLP-1 RA class, which includes other medications like Ozempic (semaglutide) and Victoza (liraglutide). These drugs work similarly to improve blood sugar levels but may differ in efficacy, dosing frequency, side effect profiles, and cardiovascular outcomes.
What is the Mechanism of Action for Trulicity?
Trulicity mimics the action of the natural incretin hormone GLP-1. It stimulates insulin secretion, suppresses glucagon secretion, slows gastric emptying, and reduces appetite, all of which contribute to lowering blood glucose levels [2].
What are the Potential Side Effects of Trulicity?
Common side effects of Trulicity include nausea, vomiting, diarrhea, abdominal pain, and decreased appetite. More serious side effects, though less common, can include pancreatitis, gallbladder problems, and hypoglycemia, especially when used with other diabetes medications [2].
What is the Patient Support Program for Trulicity?
Eli Lilly offers patient assistance programs for Trulicity, aiming to help eligible individuals access the medication. Details can often be found on the manufacturer's website or through healthcare providers.
---
Sources:
[1] https://drugpatentwatch.com
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733419
[3] https://www.nejm.org/doi/full/10.1056/NEJMoa1814235